+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioanalytical Testing Services Market - Global Forecast to 2030- Product Image
Bioanalytical Testing Services Market - Global Forecast to 2030- Product Image
Sale

Bioanalytical Testing Services Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011342
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioanalytical Testing Services Market grew from USD 4.74 billion in 2024 to USD 5.22 billion in 2025. It is expected to continue growing at a CAGR of 9.66%, reaching USD 8.25 billion by 2030.

The bioanalytical testing services sector underpins critical decision-making in drug development, diagnostics and biologics safety. Leveraging advanced analytical methods, laboratories deliver precise characterization of molecules, cell responses and biological pathways, ensuring patient safety and regulatory compliance. This executive summary delivers an expert overview of current market dynamics, emerging trends and strategic implications. It begins by contextualizing industry challenges, including evolving regulatory frameworks and technological breakthroughs, then explores transformative shifts reshaping service models.

By examining the cumulative impact of new tariff policies in the United States and integrating key segmentation, regional and competitive insights, this document offers a holistic view of the market landscape. Decision-makers will gain clarity on where investments can enhance operational resilience, how to capitalize on cutting-edge platforms and which geographies promise the greatest growth potential. Actionable recommendations guide industry leaders in optimizing their portfolios, forging strategic partnerships and aligning capabilities with future demands. Ultimately, this summary equips stakeholders with a clear roadmap for navigating complexities and seizing opportunities in a rapidly evolving bioanalytical ecosystem.

Transformative Shifts in the Bioanalytical Testing Landscape

Technological innovation and shifting research paradigms have triggered transformative changes within bioanalytical testing. The advent of integrated cell-based assays coupled with high-resolution chromatography techniques has elevated analytical precision, enabling researchers to dissect complex biological interactions at unprecedented depth. Simultaneously, molecular testing platforms-from next-generation sequencing to digital PCR-have accelerated throughput, fostering faster decision cycles in drug discovery.

Moreover, the convergence of artificial intelligence and automation has streamlined data processing, reducing variability and enabling predictive analytics in assay development. Laboratories are adopting hybrid models that blend in-house capabilities with outsourcing partnerships to balance cost, flexibility and quality. As collaboration intensifies across academia, industry and regulatory bodies, service providers are reinventing operational frameworks to support end-to-end workflows, from biomarker identification through clinical validation. These shifts underscore a new era in which agility, technological integration and strategic alliances define competitive differentiation.

Cumulative Impact of United States Tariffs 2025

The imposition of updated U.S. tariffs in 2025 has reverberated across the bioanalytical services value chain. Import duties on critical reagents, consumables and instrument components have elevated operational expenditures, compelling laboratories to reassess supply-chain resilience. Consequently, many organizations are negotiating long-term contracts with domestic manufacturers and diversifying vendor portfolios to mitigate cost fluctuations.

In response, service providers are intensifying localization efforts, establishing regional hubs for reagent production and calibration services. This strategic pivot enhances supply reliability and shortens lead times, thereby preserving project timelines. At the same time, regulatory authorities are refining guidelines to address the impact of tariffs on cross-border collaborations, prompting companies to invest in compliance resources. Ultimately, the cumulative effect of these trade policies is driving innovation in procurement strategies and reinforcing the importance of agile, regionally optimized infrastructure.

Key Segmentation Insights in the Bioanalytical Testing Market

A nuanced examination of testing type reveals that cell-based assays now encompass cytotoxicity, proliferation and viability analyses, offering insights into cellular responses with greater fidelity. Chromatography methodologies-spanning gas, liquid and supercritical fluid techniques-continue to dominate workflows for small-molecule separation, while molecular testing modalities such as next-generation sequencing, PCR and Sanger sequencing enable high-throughput genotyping and transcriptomic profiling. Spectroscopy platforms, including infrared, mass and NMR approaches, round out the analytical toolkit, supporting structural elucidation and quantitative analysis.

From an end-user perspective, biotechnology companies engaged in genetic engineering and foundational research represent a dynamic segment, while contract research organizations specializing in preclinical work and Phase I-IV trials offer turnkey services for clinical pipelines. Pharmaceutical companies focusing on drug development and late-stage clinical evaluation remain key drivers of demand. Application-centric insights highlight biologics testing for monoclonal antibodies and recombinant proteins, diagnostics modules addressing cancer and infectious disease screening, and drug discovery efforts centered on lead identification and mechanism-of-action studies.

Test offering segmentation distinguishes custom testing-encompassing specialized assays and tailored drug analyses-from standard testing, which prioritizes regulatory compliance and routine protocols. Meanwhile, technology segmentation underscores the significance of fluorescence-activated cell sorting for cell analysis, high-performance liquid chromatography in separation science, and liquid chromatography-mass spectrometry as a unified detection and quantification solution. Together, these segmentation lenses enable service providers to align capabilities with specific research requirements and end-user expectations, illuminating strategic pathways for differentiation and growth.

Key Regional Insights Driving Market Dynamics

Geographic dynamics continue to shape strategic planning within the bioanalytical services industry. In the Americas, robust investment in biotechnology infrastructure and streamlined regulatory pathways foster an environment conducive to early-stage assay development and clinical validation. Laboratories in North America are leveraging advanced data analytics and automation to drive operational excellence and high-capacity throughput.

Across Europe, the Middle East and Africa, diverse regulatory regimes and varying market maturity levels demand tailored entry strategies. Western Europe leads in harmonized guidelines and translational research collaborations, while emerging markets in the Middle East and Africa present opportunities for capacity building and technology transfer initiatives. Harmonization efforts by regional regulatory bodies are gradually lowering barriers to cross-border partnerships.

The Asia-Pacific region stands out for rapid expansion of biologics manufacturing and contract research hubs. China, India and Southeast Asian markets benefit from cost efficiencies and growing talent pools, attracting major global service providers. Government incentives and public-private collaborations are accelerating infrastructure development, positioning the region as a key node for large-scale bioanalytical operations.

These regional distinctions underscore the need for agile market entry strategies, localized service portfolios and regulatory intelligence to capture region-specific growth.

Leading Companies Shaping the Bioanalytical Testing Industry

Industry leaders are navigating an increasingly competitive landscape characterized by consolidation, specialization and global expansion. Absorption Systems LLC and Celerion, Inc. are advancing preclinical platforms with integrated safety pharmacology, while Eurofins Scientific SE and Laboratory Corporation of America Holdings expand their global footprints through strategic acquisitions. Charles River Laboratories International, Inc. and WuXi AppTec Co., Ltd. continue to scale end-to-end offerings, combining biologics characterization with clinical trial support.

Specialist providers such as BioAgilytix Labs, LLC and Q2 Solutions focus on immunoassay development and biomarker quantification, whereas Parexel International Corporation and IQVIA Holdings Inc. integrate data analytics services to accelerate drug development timelines. Frontage Laboratories, Inc. and NorthEast BioAnalytical Laboratories LLC enhance regional capacity in North America and Asia, reflecting a trend toward decentralized service networks. Medpace Holdings, Inc. and Syneos Health, LLC are reinforcing consulting capabilities to guide clients through complex regulatory and operational challenges.

New entrants like Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd. bring tailored assay solutions to niche markets, and Intertek Group PLC leverages its quality assurance expertise to support regulatory compliance testing. Together, these organizations illustrate how strategic positioning, technological leadership and geographic reach define competitive advantage in bioanalytical testing services.

Actionable Recommendations for Industry Leaders

To thrive in this dynamic environment, industry leaders should prioritize investment in advanced automation and data analytics platforms that enhance throughput and minimize variability. Collaborating with reagent and equipment manufacturers to secure preferential supply agreements will reduce exposure to tariff-related cost volatility. Establishing regional centers of excellence-equipped with modular, scalable infrastructure-will support rapid response to client requirements while optimizing operational efficiency.

Strategic alliances with contract research organizations and academic institutions can drive innovation in assay development, particularly in emerging modalities such as cell-based immunoassays and high-content screening. Tailoring service portfolios to segment-specific needs, whether in biologics characterization, diagnostics or drug discovery, will enable providers to capture higher-value opportunities. Moreover, cultivating a strong regulatory affairs function will streamline compliance across diverse geographies and emerging markets.

Finally, embedding sustainability practices within laboratory operations-notably in waste reduction and energy management-can differentiate service providers while aligning with evolving corporate responsibility standards. By executing these recommendations, leaders will position themselves to capitalize on market shifts, regulatory changes and technological breakthroughs.

Conclusion and Strategic Outlook

The bioanalytical testing services market is at a pivotal juncture, shaped by technological integration, shifting trade policies and evolving customer expectations. By harnessing advanced analytical platforms, optimizing supply-chain resilience and aligning offerings with nuanced segmentation insights, service providers can secure sustainable competitive advantage. Regional customization and strategic partnerships will further strengthen market positioning, while robust regulatory compliance functions will mitigate operational risk.

Looking ahead, those who embrace innovation-particularly in automation, data analytics and emerging assay formats-will lead the next wave of growth. Organizational agility, underpinned by modular infrastructure and collaborative ecosystems, will be paramount. Ultimately, success will depend on a seamless fusion of scientific expertise, operational excellence and strategic foresight.

Market Segmentation & Coverage

This research report categorizes the Bioanalytical Testing Services Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Cell-Based Assays
    • Cytotoxicity Assays
    • Proliferation Assays
    • Viability Assays
  • Chromatography
    • Gas Chromatography
    • Liquid Chromatography
    • Supercritical Fluid Chromatography
  • Molecular Testing
    • NGS
    • PCR
    • Sanger Sequencing
  • Spectroscopy
    • Infrared Spectroscopy
    • Mass Spectrometry
    • NMR Spectroscopy
  • Biotechnology Companies
    • Biotechnology Research
    • Genetic Engineering
  • Contract Research Organizations
    • Phase I-IV Trials
    • Preclinical Research
  • Pharmaceutical Companies
    • Clinical Trials
    • Drug Development
  • Biologics Testing
    • Monoclonal Antibodies
    • Recombinant Proteins
  • Diagnostics
    • Cancer Diagnostics
    • Infectious Disease
  • Drug Discovery
    • Lead Identification
    • Mechanism Of Action Studies
  • Custom Testing
    • Specialized Assays
    • Tailored Drug Assays
  • Standard Testing
    • Regulatory Compliance Tests
    • Routine Tests
  • Fluorescence-Activated Cell Sorting
    • Cell Analysis
  • High-Performance Liquid Chromatography
  • Liquid Chromatography-Mass Spectrometry

This research report categorizes the Bioanalytical Testing Services Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Bioanalytical Testing Services Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Absorption Systems LLC
  • Almac Group Limited
  • Altasciences
  • BioAgilytix Labs, LLC
  • Celerion, Inc.
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • Frontage Laboratories, Inc.
  • Icon PLC
  • Intertek Group PLC
  • IQVIA Holdings Inc.
  • Laboratory Corporation of America Holdings
  • LGC Limited
  • Lotus Labs Pvt. Ltd.
  • Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd.
  • Medpace Holdings, Inc.
  • NorthEast BioAnalytical Laboratories LLC
  • Pace Analytical Services LLC
  • Parexel International Corporation
  • PPD Inc.
  • Q2 Solutions
  • SGS Société Générale de Surveillance SA
  • Syneos Health, LLC
  • WuXi AppTec Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioanalytical Testing Services Market, by Testing Type
8.1. Introduction
8.2. Cell-Based Assays
8.2.1. Cytotoxicity Assays
8.2.2. Proliferation Assays
8.2.3. Viability Assays
8.3. Chromatography
8.3.1. Gas Chromatography
8.3.2. Liquid Chromatography
8.3.3. Supercritical Fluid Chromatography
8.4. Molecular Testing
8.4.1. NGS
8.4.2. PCR
8.4.3. Sanger Sequencing
8.5. Spectroscopy
8.5.1. Infrared Spectroscopy
8.5.2. Mass Spectrometry
8.5.3. NMR Spectroscopy
9. Bioanalytical Testing Services Market, by End User
9.1. Introduction
9.2. Biotechnology Companies
9.2.1. Biotechnology Research
9.2.2. Genetic Engineering
9.3. Contract Research Organizations
9.3.1. Phase I-IV Trials
9.3.2. Preclinical Research
9.4. Pharmaceutical Companies
9.4.1. Clinical Trials
9.4.2. Drug Development
10. Bioanalytical Testing Services Market, by Application
10.1. Introduction
10.2. Biologics Testing
10.2.1. Monoclonal Antibodies
10.2.2. Recombinant Proteins
10.3. Diagnostics
10.3.1. Cancer Diagnostics
10.3.2. Infectious Disease
10.4. Drug Discovery
10.4.1. Lead Identification
10.4.2. Mechanism Of Action Studies
11. Bioanalytical Testing Services Market, by Test Offering
11.1. Introduction
11.2. Custom Testing
11.2.1. Specialized Assays
11.2.2. Tailored Drug Assays
11.3. Standard Testing
11.3.1. Regulatory Compliance Tests
11.3.2. Routine Tests
12. Bioanalytical Testing Services Market, by Technology
12.1. Introduction
12.2. Fluorescence-Activated Cell Sorting
12.2.1. Cell Analysis
12.3. High-Performance Liquid Chromatography
12.4. Liquid Chromatography-Mass Spectrometry
13. Americas Bioanalytical Testing Services Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Bioanalytical Testing Services Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Bioanalytical Testing Services Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Absorption Systems LLC
16.3.2. Almac Group Limited
16.3.3. Altasciences
16.3.4. BioAgilytix Labs, LLC
16.3.5. Celerion, Inc.
16.3.6. Charles River Laboratories International, Inc.
16.3.7. Eurofins Scientific SE
16.3.8. Frontage Laboratories, Inc.
16.3.9. Icon PLC
16.3.10. Intertek Group PLC
16.3.11. IQVIA Holdings Inc.
16.3.12. Laboratory Corporation of America Holdings
16.3.13. LGC Limited
16.3.14. Lotus Labs Pvt. Ltd.
16.3.15. Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd.
16.3.16. Medpace Holdings, Inc.
16.3.17. NorthEast BioAnalytical Laboratories LLC
16.3.18. Pace Analytical Services LLC
16.3.19. Parexel International Corporation
16.3.20. PPD Inc.
16.3.21. Q2 Solutions
16.3.22. SGS Société Générale de Surveillance SA
16.3.23. Syneos Health, LLC
16.3.24. WuXi AppTec Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BIOANALYTICAL TESTING SERVICES MARKET MULTI-CURRENCY
FIGURE 2. BIOANALYTICAL TESTING SERVICES MARKET MULTI-LANGUAGE
FIGURE 3. BIOANALYTICAL TESTING SERVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TEST OFFERING, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TEST OFFERING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BIOANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BIOANALYTICAL TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOANALYTICAL TESTING SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CYTOTOXICITY ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PROLIFERATION ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIABILITY ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SUPERCRITICAL FLUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY INFRARED SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHASE I-IV TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICS TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICS TESTING, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LEAD IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MECHANISM OF ACTION STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TEST OFFERING, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CUSTOM TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECIALIZED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TAILORED DRUG ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CUSTOM TESTING, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STANDARD TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY REGULATORY COMPLIANCE TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY ROUTINE TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STANDARD TESTING, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY FLUORESCENCE-ACTIVATED CELL SORTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY FLUORESCENCE-ACTIVATED CELL SORTING, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICS TESTING, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TEST OFFERING, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CUSTOM TESTING, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STANDARD TESTING, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY FLUORESCENCE-ACTIVATED CELL SORTING, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICS TESTING, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TEST OFFERING, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CUSTOM TESTING, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STANDARD TESTING, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY FLUORESCENCE-ACTIVATED CELL SORTING, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICS TESTING, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TEST OFFERING, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CUSTOM TESTING, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STANDARD TESTING, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY FLUORESCENCE-ACTIVATED CELL SORTING, 2018-2030 (USD MILLION)
TABLE 123. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 124. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
TABLE 125. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 126. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
TABLE 127. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 128. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 130. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 131. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 132. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICS TESTING, 2018-2030 (USD MILLION)
TABLE 134. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 135. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 136. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TEST OFFERING, 2018-2030 (USD MILLION)
TABLE 137. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CUSTOM TESTING, 2018-2030 (USD MILLION)
TABLE 138. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STANDARD TESTING, 2018-2030 (USD MILLION)
TABLE 139. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY FLUORESCENCE-ACTIVATED CELL SORTING, 2018-2030 (USD MILLION)
TABLE 141. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 142. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
TABLE 143. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 144. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
TABLE 145. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 146. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 148. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 149. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 150. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICS TESTING, 2018-2030 (USD MILLION)
TABLE 152. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 153. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 154. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TEST OFFERING, 2018-2030 (USD MILLION)
TABLE 155. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CUSTOM TESTING, 2018-2030 (USD MILLION)
TABLE 156. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STANDARD TESTING, 2018-2030 (USD MILLION)
TABLE 157. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY FLUORESCENCE-ACTIVATED CELL SORTING, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICS TESTING, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TEST OFFERING, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CUSTOM TESTING, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STANDARD TESTING, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY FLUORESCENCE-ACTIVATED CELL SORTING, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 178. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
TABLE 180. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
TABLE 182. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 186. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICS TESTING, 2018-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 190. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TEST OFFERING, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CUSTOM TESTING, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STANDARD TESTING, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY FLUORESCENCE-ACTIVATED CELL SORTING, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 197. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 198. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
TABLE 199. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 200. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
TABLE 201. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 202. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 204. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 205. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 206. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICS TESTING, 2018-2030 (USD MILLION)
TABLE 208. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 209. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 210. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TEST OFFERING, 2018-2030 (USD MILLION)
TABLE 211. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CUSTOM TESTING, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STANDARD TESTING, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY FLUORESCENCE-ACTIVATED CELL SORTING, 2018-2030 (USD MILLION)
TABLE 215. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 216. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
TABLE 217. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 218. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
TABLE 219. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 220. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 222. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 223. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 224. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICS TESTING, 2018-2030 (USD MILLION)
TABLE 226. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 227. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 228. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TEST OFFERING, 2018-2030 (USD MILLION)
TABLE 229. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CUSTOM TESTING, 2018-2030 (USD MILLION)
TABLE 230. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STANDARD TESTING, 2018-2030 (USD MILLION)
TABLE 231. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY FLUORESCENCE-ACTIVATED CELL SORTING, 2018-2030 (USD MILLION)
TABLE 233. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 234. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
TABLE 235. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 236. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
TABLE 237. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 238. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 240. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 241. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 242. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICS TESTING, 2018-2030 (USD MILLION)
TABLE 244. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 245. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 246. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TEST OFFERING, 2018-2030 (USD MILLION)
TABLE 247. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CUSTOM TESTING, 2018-2030 (USD MILLION)
TABLE 248. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STANDARD TESTING, 2018-2030 (USD MILLION)
TABLE 249. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY FLUORESCENCE-ACTIVATED CELL SORTING, 2018-2030 (USD MILLION)
TABLE 251. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 252. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
TABLE 253. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 254. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
TABLE 255. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 256. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 258. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 259. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 260. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICS TESTING, 2018-2030 (USD MILLION)
TABLE 262. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 263. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 264. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TEST OFFERING, 2018-2030 (USD MILLION)
TABLE 265. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CUSTOM TESTING, 2018-2030 (USD MILLION)
TABLE 266. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STANDARD TESTING, 2018-2030 (USD MILLION)
TABLE 267. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY FLUORESCENCE-ACTIVATED CELL SORTING, 2018-2030 (USD MILLION)
TABLE 269. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 270. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
TABLE 271. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 272. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
TABLE 273. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 274. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 276. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 277. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 278. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICS TESTING, 2018-2030 (USD MILLION)
TABLE 280. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 281. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 282. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TEST OFFERING, 2018-2030 (USD MILLION)
TABLE 283. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CUSTOM TESTING, 2018-2030 (USD MILLION)
TABLE 284. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STANDARD TESTING, 2018-2030 (USD MILLION)
TABLE 285. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 286. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY FLUORESCENCE-ACTIVATED CELL SORTING, 2018-2030 (USD MILLION)
TABLE 287. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 288. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
TABLE 289. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 290. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR TESTING, 2018-2030 (USD MILLION)
TABLE 291. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 292. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 294. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICS TESTING, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA BIOANALYTICAL TESTING SERVICE

Companies Mentioned

  • Absorption Systems LLC
  • Almac Group Limited
  • Altasciences
  • BioAgilytix Labs, LLC
  • Celerion, Inc.
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • Frontage Laboratories, Inc.
  • Icon PLC
  • Intertek Group PLC
  • IQVIA Holdings Inc.
  • Laboratory Corporation of America Holdings
  • LGC Limited
  • Lotus Labs Pvt. Ltd.
  • Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd.
  • Medpace Holdings, Inc.
  • NorthEast BioAnalytical Laboratories LLC
  • Pace Analytical Services LLC
  • Parexel International Corporation
  • PPD Inc.
  • Q2 Solutions
  • SGS Société Générale de Surveillance SA
  • Syneos Health, LLC
  • WuXi AppTec Co., Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Bioanalytical Testing Services in CRO Market Size, Share & Trends Analysis Report by Molecule (Small, Large), Test (Bioavailability, Bioequivalence), Test, Workflow, End-Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Bioanalytical Testing Services in CRO Market Size, Share & Trends Analysis Report by Molecule (Small, Large), Test (Bioavailability, Bioequivalence), Test, Workflow, End-Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 180 Pages
  • Global
From
Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis Report by Phase (Preclinical, Clinical), Test (ADME, PD), Type, Therapeutic Area, End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis Report by Phase (Preclinical, Clinical), Test (ADME, PD), Type, Therapeutic Area, End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Bioanalytical Testing Service Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application - Product Image

Bioanalytical Testing Service Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

  • Report
  • 126 Pages
  • Global
From
Bioanalytical Testing Services Market Report by Molecule Type, Test Type, Workflow, and Region 2024-2032 - Product Image

Bioanalytical Testing Services Market Report by Molecule Type, Test Type, Workflow, and Region 2024-2032

  • Report
  • 140 Pages
  • Global
From
Bioanalytical Testing Services - Global Strategic Business Report - Product Image

Bioanalytical Testing Services - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From

About the Bioanalytical Testing Services Market

Bioanalytical Testing Services are a type of biotechnology that focuses on the analysis of biological samples. These services are used to measure the concentration of drugs, metabolites, and other substances in biological samples such as blood, urine, and tissue. Bioanalytical Testing Services are used to assess the safety and efficacy of drugs, biologics, and medical devices. They are also used to monitor the levels of therapeutic drugs in patients, as well as to detect and quantify biomarkers for disease diagnosis and prognosis. Bioanalytical Testing Services are provided by a variety of companies, including Eurofins Scientific, LabCorp, and Charles River Laboratories. Other companies in the market include WuXi AppTec, PPD, and Covance. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.